---
title: "Hengrui Pharma signed a cooperation agreement with the Hong Kong Greater China Cancer Foundation"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/267002393.md"
description: "Recently, Hengrui Pharma signed a partnership agreement with the Hong Kong Greater China Cancer Fund in Hong Kong as a caring corporate partner under the NPP program, aiming to provide advanced clinical options for breast cancer patients in Hong Kong who urgently need innovative therapies. According to the agreement, both parties will provide Hengrui Pharma's innovative targeted drug—Pyrotinib Maleate Tablets—to breast cancer patients in Hong Kong public hospitals under the \"Designated Patient Drug Use Program.\""
datetime: "2025-11-22T04:47:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267002393.md)
  - [en](https://longbridge.com/en/news/267002393.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267002393.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/267002393.md) | [繁體中文](https://longbridge.com/zh-HK/news/267002393.md)


# Hengrui Pharma signed a cooperation agreement with the Hong Kong Greater China Cancer Foundation

Recently, Hengrui Pharma signed a partnership agreement with the Hong Kong Greater China Cancer Fund in Hong Kong as a caring corporate partner under the NPP program, aiming to provide advanced clinical options for breast cancer patients in Hong Kong who urgently need innovative therapies. According to the agreement, both parties will provide Hengrui Pharma's innovative targeted drug—Pyrotinib Maleate Tablets—to breast cancer patients in public hospitals in Hong Kong under the "Designated Patient Drug Use Program."

### 相关股票

- [Hengrui Pharma (600276.CN)](https://longbridge.com/zh-CN/quote/600276.CN.md)
- [HENGRUI PHARMA (01276.HK)](https://longbridge.com/zh-CN/quote/01276.HK.md)

## 相关资讯与研究

- [Hengrui Pharma Unit Gets China Nod for New Indication of Cancer Drug](https://longbridge.com/zh-CN/news/279944925.md)
- [Hengrui Pharma Gets Nod to Trial Six Drugs](https://longbridge.com/zh-CN/news/271064302.md)
- [Biocytogen and Sihuan partner to advance new therapeutics for weight loss](https://longbridge.com/zh-CN/news/281501537.md)
- [Astellas Speeds Pipeline, Eyes 10 Late-Stage Drugs by 2034](https://longbridge.com/zh-CN/news/281117306.md)
- [Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call](https://longbridge.com/zh-CN/news/281187029.md)